We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.14B
AUM Growth
-$171M
(-5.2%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
16.05%
Holding
444
New
72
Increased
89
Reduced
94
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$29.5M |
| 2 |
Middleby
MIDD
|
+$25.9M |
| 3 |
Parker-Hannifin
PH
|
+$25.1M |
| 4 |
Veeva Systems
VEEV
|
+$23M |
| 5 |
Dick's Sporting Goods
DKS
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$43.4M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$35.2M |
| 3 |
TransDigm Group
TDG
|
+$29.9M |
| 4 |
Visa
V
|
+$28.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Energy | 16.11% |
| 3 | Healthcare | 14.04% |
| 4 | Industrials | 13.84% |
| 5 | Consumer Discretionary | 11.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
SS&C Technologies
SSNC
$19.1B
| $3.54M | 0.11% |
123,666
+4,270
| +4% | +$132K |
|
227
CDW
CDW
$19.2B
| $3.52M | 0.11% |
+67,505
| New | +$3.29M |
|
228
Prosperity Bancshares
PB
$8.53B
| $3.5M | 0.11% |
+48,690
| New | +$3.04M |
|
229
Idexx Laboratories
IDXX
$40.2B
| $3.45M | 0.11% |
29,405
+1,020
| +4% | +$116K |
|
230
Westlake Corp
WLK
$8.95B
| $3.43M | 0.11% |
+61,220
| New | +$3.34M |
|
231
PTC
PTC
$14.4B
| $3.43M | 0.11% |
+74,035
| New | +$3.46M |
|
|
X
232
DELISTED
US Steel
X
| $3.35M | 0.11% |
101,470
+15,770
| +18% | +$422K |
|
|
OPLN
233
Openlane
OPLN
$4.26B
| $3.32M | 0.11% |
205,680
+6,975
| +4% | +$111K |
|
234
Toyota
TM
$231B
| $3.29M | 0.11% |
28,100
| – | – |
|
235
Allison Transmission
ALSN
$10.1B
| $3.27M | 0.1% |
+97,180
| New | +$3.02M |
|
236
SPDR Gold Trust
GLD
$145B
| $3.12M | 0.1% |
28,500
| – | – |
|
237
iShares Russell 1000 Growth ETF
IWF
$123B
| $3M | 0.1% |
114,400
| – | – |
|
238
Varonis Systems
VRNS
$5.45B
| $2.95M | 0.09% |
330,471
-389,511
| -54% | -$3.7M |
|
239
Kohl's
KSS
$1.85B
| $2.93M | 0.09% |
+59,320
| New | +$2.94M |
|
240
LKQ Corp
LKQ
$5.92B
| $2.92M | 0.09% |
95,229
-49,310
| -34% | -$1.61M |
|
|
CMD
241
DELISTED
Cantel Medical Corporation
CMD
| $2.85M | 0.09% |
36,254
-92,600
| -72% | -$7.2M |
|
|
ANDV
242
DELISTED
Andeavor
ANDV
| $2.76M | 0.09% |
31,600
| – | – |
|
|
DM
243
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $2.71M | 0.09% |
91,638
| – | – |
|
244
Cheniere Energy
CQP
$31.8B
| $2.69M | 0.09% |
93,280
| – | – |
|
|
XYZ
245
Block Inc
XYZ
$47B
| $2.69M | 0.09% |
+197,075
| New | +$2.45M |
|
246
Valero Energy
VLO
$114B
| $2.6M | 0.08% |
38,000
| – | – |
|
|
DCP
247
DELISTED
DCP Midstream, LP
DCP
| $2.5M | 0.08% |
+65,130
| New | +$2.28M |
|
|
UNT
248
DELISTED
UNIT Corporation
UNT
| $2.46M | 0.08% |
91,430
| – | – |
|
249
Alkermes
ALKS
$7.72B
| $2.42M | 0.08% |
43,490
-31,315
| -42% | -$1.67M |
|
|
PE
250
DELISTED
PARSLEY ENERGY INC
PE
| $2.41M | 0.08% |
68,385
-23,785
| -26% | -$842K |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q4 2016 Portfolio in Review
As of Q4 2016, Castleark Management held 444 positions worth $3.14B, down 5.2% from $3.31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Castleark Management withdrew a net $231M in Q4 2016, closing 73 positions and reducing 94 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $22.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Castleark Management opened a new position in Morgan Stanley worth $32.9M.
- Castleark Management's largest Q4 2016 buy was Morgan Stanley: 779,714 shares worth $32.9M.
- Castleark Management added most to Middleby in Q4 2016, an estimated $25.9M increase.
- Castleark Management's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $43.4M.
- Castleark Management fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $22.8M.
- Castleark Management's ten largest holdings make up 16% of its $3.14B portfolio in Q4 2016.
- Castleark Management opened 72 new positions and closed 73 in Q4 2016.
- Castleark Management's portfolio value fell 5.2% quarter-over-quarter to $3.14B.
Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.